151 related articles for article (PubMed ID: 3447890)
1. Statistical properties of a two-stage model of carcinogenesis.
Portier CJ
Environ Health Perspect; 1987 Dec; 76():125-31. PubMed ID: 3447890
[TBL] [Abstract][Full Text] [Related]
2. Risk assessment of nongenotoxic carcinogens based upon cell proliferation/death rates in rodents.
Gaylor DW; Zheng Q
Risk Anal; 1996 Apr; 16(2):221-5. PubMed ID: 8638041
[TBL] [Abstract][Full Text] [Related]
3. Bioassays of shortened duration for drugs: statistical implications.
Kodell RL; Lin KK; Thorn BT; Chen JJ
Toxicol Sci; 2000 Jun; 55(2):415-32. PubMed ID: 10828275
[TBL] [Abstract][Full Text] [Related]
4. Assessing the effects of metabolism of environmental agents on cancer tumor development by a two-stage model of carcinogenesis.
Tan WY; Singh KP
Environ Health Perspect; 1987 Oct; 74():203-10. PubMed ID: 3691427
[TBL] [Abstract][Full Text] [Related]
5. Two-stage models of carcinogenesis, classification of agents, and design of experiments.
Portier CJ; Edler L
Fundam Appl Toxicol; 1990 Apr; 14(3):444-60. PubMed ID: 2340975
[TBL] [Abstract][Full Text] [Related]
6. [Experimental models of 2-stage carcinogenesis].
Turusov VS
Eksp Onkol; 1985; 7(3):5-12. PubMed ID: 3893973
[TBL] [Abstract][Full Text] [Related]
7. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication No. 13. The need for biological risk assessment in reaching decisions about carcinogens.
Clayson DB
Mutat Res; 1987 May; 185(3):243-69. PubMed ID: 3574332
[TBL] [Abstract][Full Text] [Related]
8. Receptor-mediated biological processes: implications for evaluating carcinogens.
Silbergeld E
Prog Clin Biol Res; 1994; 387():273-93. PubMed ID: 7972252
[No Abstract] [Full Text] [Related]
9. Two-stage and Weibull models for carcinogenesis applied to the ED01 discontinued dosing data.
Kodell RL; Felton RP
Environ Health Perspect; 1991 May; 92():155-66. PubMed ID: 1935845
[TBL] [Abstract][Full Text] [Related]
10. The natural history of carcinogenesis: implications of experimental carcinogenesis in the genesis of human cancer.
Pitot HC; Goldsworthy T; Moran S
J Supramol Struct Cell Biochem; 1981; 17(2):133-46. PubMed ID: 7033553
[No Abstract] [Full Text] [Related]
11. Thresholds in carcinogenicity in ED01 study.
Rozman KK
Toxicol Sci; 2003 Sep; 75(1):224-5. PubMed ID: 12923303
[No Abstract] [Full Text] [Related]
12. A measure of tumorigenic potency incorporating dose-response shape.
Meier KL; Bailer AJ; Portier CJ
Biometrics; 1993 Sep; 49(3):917-26. PubMed ID: 8241378
[TBL] [Abstract][Full Text] [Related]
13. Modeling the effect of dose on the lifetime tumor rate from an animal carcinogenicity experiment.
Finkelstein DM
Biometrics; 1991 Jun; 47(2):669-80. PubMed ID: 1912266
[TBL] [Abstract][Full Text] [Related]
14. Interaction between two carcinogens in the two-stage clonal expansion model of carcinogenesis.
Zielinski J; Kodell R; Krewski D
J Epidemiol Biostat; 2001; 6(2):219-28. PubMed ID: 11434501
[TBL] [Abstract][Full Text] [Related]
15. Combination effects in chemical carcinogenesis (experimental results).
Schmähl D
Oncology; 1976; 33(2):73-6. PubMed ID: 985603
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular mechanisms of multistep carcinogenesis: relevance to carcinogen risk assessment.
Barrett JC; Wiseman RW
Environ Health Perspect; 1987 Dec; 76():65-70. PubMed ID: 3447905
[TBL] [Abstract][Full Text] [Related]
17. Waddell's representation of the tumor incidence data of the ED01 study is strongly misleading.
Lutz WK
Toxicol Sci; 2003 Sep; 75(1):223; author reply 223-4. PubMed ID: 12923302
[No Abstract] [Full Text] [Related]
18. [Terminology of carcinogenesis in light of the current concepts of the mechanisms of action of chemical carcinogens].
Khudoleĭ VV; Pliss GB; Schramm T
Eksp Onkol; 1986; 8(5):63-74. PubMed ID: 3780516
[TBL] [Abstract][Full Text] [Related]
19. Uncertainty estimates for low-dose-rate extrapolations of animal carcinogenicity data.
Guess H; Crump K; Peto R
Cancer Res; 1977 Oct; 37(10):3475-83. PubMed ID: 908002
[No Abstract] [Full Text] [Related]
20. Dose response problems in carcinogenesis.
Crump KS
Biometrics; 1979 Mar; 35(1):157-67. PubMed ID: 497333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
